Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [966]
News [1599]
Articles [144]
Editorials [3]
Conferences [128]
elearning [41]
The relationship between mobility and polypharmacy
Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA
The relationship between mobility and polypharmacy ( Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA )
29 Nov 2019
Do older patients prioritise survival or quality of life?
Dr Enrique Soto - National Institute of Medical Sciences, Mexico City, Mexico
Do older patients prioritise survival or quality of life? ( Dr Enrique Soto - National Institute of Medical Sciences, Mexico City, Mexico )
29 Nov 2019
New approaches and highlights from SIOG 2019
Dr Hans Wildiers - President, SIOG
New approaches and highlights from SIOG 2019 ( Dr Hans Wildiers - President, SIOG )
29 Nov 2019
The young SIOG interest group
Dr Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK
The young SIOG interest group ( Dr Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK )
29 Nov 2019
The importance of proper geriatric classification for haematological...
Dr Raúl Cordoba - Jiménez Diaz Foundation University Hospital, Madrid, Spain
The importance of proper geriatric classification for haematological malignancies ( Dr Raúl Cordoba - Jiménez Diaz Foundation University Hospital, Madrid, Spain )
29 Nov 2019
The many faces of geriatric oncology
Prof Holly Holmes - University of Texas, Houston, USA
The many faces of geriatric oncology ( Prof Holly Holmes - University of Texas, Houston, USA )
29 Nov 2019
Realising the potential of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Immunogenicity of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Simplifying molecular subtypes of metastatic gastric cancer
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
Simplifying molecular subtypes of metastatic gastric cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )
8 Oct 2019
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma
Dr Jonathan Ledermann - University College Hospital, London, UK
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma ( Dr Jonathan Ledermann - University College Hospital, London, UK )
7 Oct 2019
Optimal timing of radiotherapy following radical prostatectomy
Prof Chris Parker - The Royal Marsden Hospital, London, UK
Optimal timing of radiotherapy following radical prostatectomy ( Prof Chris Parker - The Royal Marsden Hospital, London, UK )
4 Oct 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation